Cybin Inc. (OTCMKTS:CLXPF – Get Free Report)’s stock price reached a new 52-week high on Monday . The company traded as high as $11.66 and last traded at $10.92, with a volume of 201506 shares. The stock had previously closed at $11.41.
Cybin Price Performance
The company’s fifty day simple moving average is $4.56 and its 200-day simple moving average is $1.81. The firm has a market capitalization of $1.62 billion and a PE ratio of -47.38.
About Cybin
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
See Also
- Five stocks we like better than Cybin
- What is a Dividend King?
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- How to Invest in Biotech Stocks
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
